The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Haresh Kapurlal Mehta, a promoter of Medico Remedies Ltd, sold 1,00,000 equity shares (0.12% of total share capital) through an open market transaction on 28 March 2025. As a result, his shareholding in the company declined from 1,72,29,200 shares (20.76%) to 1,71,29,200 shares (20.64%). The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations. The total equity share capital of the company remains at 8,29,84,000 shares of Rs. 2 each, worth Rs. 16.59 crore. The sale is small in size and the promoter's overall stake remains comfortable at over 20%.
This is a minor promoter sell-off (only 0.12% of equity) and is unlikely to meaningfully affect the stock price or signal any major concern. The promoter continues to hold a significant 20.64% stake, so long-term confidence in the company remains largely intact.